Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS5599323 A
Publication typeGrant
Application numberUS 08/550,494
Publication dateFeb 4, 1997
Filing dateOct 30, 1995
Priority dateJul 12, 1991
Fee statusLapsed
Also published asCA2111985A1, DE787502T1, DE69224065D1, DE69224065T2, DE69233602D1, DE69233602T2, EP0594782A1, EP0594782B1, EP0787502A2, EP0787502A3, EP0882468A2, EP0882468A3, EP0882468B1, US5462535, US5462535, US5984906, WO1993000948A1
Publication number08550494, 550494, US 5599323 A, US 5599323A, US-A-5599323, US5599323 A, US5599323A
InventorsFrits F. Bonnichsen, Peter N. J.o slashed.rgensen
Original AssigneeNovo Nordisk A/S
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Syringe system
US 5599323 A
Abstract
An insulin injection system comprises a pen shaped syringe with a cartridge containing insulin, and an injection needle. The needle is a G30 needle and the insulin is a type which may freely flow through a G 30 needle. When the insulin is the type comprising suspended crystals the maximal dimension of any crystal is 15 μm.
Images(2)
Previous page
Next page
Claims(4)
We claim:
1. A needle assembly comprising:
(a) a needle hub having a base and a standard insulin needle fitting for removably mounting said needle assembly on a pen-type insulin syringe having a standard mounting and which accepts cartridges containing only insulin types that may flow freely through a G30 needle; and
(b) a G30 needle secured in said base and having first and second needle portions extending from said base in opposite directions.
2. A needle assembly according to claim 1, wherein said standard fitting includes an annular sleeve extending from said base such that said sleeve surrounds said first needle portion concentrically and is spaced therefrom, and wherein said sleeve has a threaded interior by which it may be screwed onto a standard, externally threaded, hub-receiving part of a pen-type insulin syringe.
3. A needle assembly according to claim 2, and wherein said second needle portion has a predetermined length appropriate for injecting insulin into a human patient.
4. A needle assembly according to claim 3, wherein said base further comprises a central protrusion which extends from said base for a predetermined distance along said second needle portion and embeds said second needle portion along the said distance, and wherein said second needle portion further comprises an exposed end which projects axially from said central protrusion and which has a length corresponding to the desired depth of needle insertion into a human patient.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of Ser. No. 08/323,401 filed Oct. 14, 1994 now U.S. Pat. No. 5,462,535 which is a continuation-in-part of U.S. Ser. No. 08/167,831 filed Dec. 16, 1993, now abandoned which is a continuation of PCT/DK92/00212 filed Jul. 2, 1992, the contents of which are incorporated herein by reference in their entirety.

BACKGROUND OF THE INVENTION

The invention relates to syringes for injecting insulin and more specified pen-shaped syringes administering insulin doses from a cartridge in the pen syringe.

Diabetes is usually treated by the patient frequently injecting himself with an insulin dose which he adjusts each time according to his immediate need.

To make it less straining to the patient to prick himself several times a day, it is aspired to make the injections as painless as possible and to reduce the physical malaise many people will feel if they have to pass a needle into their own body.

As the malaise seems to grow with the length and the thickness of the needle and the sensation of pain seems to be reduced when the needle is made thinner, a passable way seems to be to make the needle thinner and shorter. This line may, of course, only be followed to a certain extent, as the needle must have a length permitting the subcutaneous injection of the insulin and a thickness allowing the inulin to pass through the needle.

Whereas the acceptable minimum length of the needle is well defined, the lower limit for the thickness of the needle is more fluid. With a thinner needle it becomes more difficult to press the insulin out through the needle and the injections will take more time. A more relevant lower limit is set by the fact that by injecting insulin types appearing as suspended crystals, a sieving of the suspension may occur, and the suspension injected may consequently have a lower concentration than expected.

The thickness of needles are indicated by a "G" and a gauge number increasing with thinner needles. Thus, the outer diameter of a G 27 needle is 0.4 mm, of a G 28 needle 0.36 mm, and of a G 30 needle 0.3 mm. The wall thickness of the needles is typically 0.075 mm, so that a G 27 needle has bore of 0.25 mm, whereas the bore of a G 30 needle is 0.15 mm.

Commonly, G 27 needles are used. However, according to Diabetes Forecast 1976; 29 page 27 problems are observed when G 27 needles and even thicker needles are used for injecting an insulin containing suspended crystals. The problem is a clogging of the needle during injection, which clogging is due to the fact that crystals of e.g. Lente insulin having a size of 20-40 μm have a tendency to align themselves across the inside of the needle. This clogging is observed during injection, especially if this injection is carried out too slowly. It must be presumed that a similar clogging occurs during the filling of the syringe thus making the filling impossible or at least having the effect that some of the crystals are retained with the consequence that the suspension sucked into the syringe has a lower concentration then expected.

Whereas the trend goes towards the use of G 28 needles this is seen as close to the limit of what is possible. G 29 needles are seen as needles for disposable syringes for insulin, but G 30 needles have so far been deemed unusable for injection of an insulin suspension.

SUMMARY OF THE INVENTION

The present invention is based on the surprising recognition that needles thinner than G 29 may be used for injecting insulin.

The present invention is, thus, related to an insulin injection system comprising a pen shaped syringe having a cartridge with insulin and an injection needle, the system being characterized in that the needle is a G 30 needle and the cartridge contains an insulin type which may flow freely through a G 30 needle.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows an injection system comprising a disposable syringe and a vial.

FIG. 2 shows an injection system according to the invention comprising a disposable pen syringe with an integrated cartridge and a needle hub with a needle.

FIG. 3 shows an injection system according to the invention comprising a reusable syringe loaded with a cartridge and carrying a needle hub with a needle.

FIG. 4 shows a needle hub with a needle according to the invention.

DETAILED DESCRIPTION OF THE INVENTION

By the use of a pen shaped syringe with a cartridge the insulin will only have to pass the needle once, which in itself halves the risk of sieving. Further, the use of suspensions of insulin types having very short and needle shaped crystals totally eliminates the risk of bridging in a G 30 needle when no dimension of the insulin crystals exceeds 15 μm.

By closely binding a G 30 needle to a system further comprising a pen-shaped syringe, it may be ensured that a pen syringe equipped with a G 30 needle will always contain insulin of a type which may pass through the needle without any sieving effect.

The pen syringe may either be manufactured as a disposable device which is sold prefilled with the insulin or it may appear as a durable pen syringe so designed that it can only receive cartridges with insulin which may pass freely through a G 30 needle.

The needle may have attaching means cooperating with attaching means on the pen syringe for mounting the needle on the pen syringe, whereby the needle hub may be designed to only match with pen syringes of the system. Such attaching means may be a needle hub having a thread cooperating with a corresponding thread on the syringe.

The needle hub may have a central protrusion covering part of the length of the needle. Thereby, the length of the injection part of the needle is made shorter, which is advantageous as well from a psychological point of view as from a mechanical one. The protrusion makes visible only the part which should be inserted and it supports the thin and consequently more fragile needle.

With an injection part of the needle of 8-12 mm, it is avoided that the injections become intermuscular instead of subcutaneous. The needles may be manufactured in the same length as usual for thicker needles and the shorter injection part may be obtained by the hub protrusion covering a larger part than usual for the needle.

FIG. 1 shows a disposable syringe comprising a tube 1 wherein a piston 2 may be displaced by pulling or pressing a piston rod 3. The syringe has an injection needle 5 integral with the tube 1. A vial 4 closed by a not shown rubber membrane contains insulin which may be sucked up into the syringe tube by piercing the membrane by the needle to immerse this needle into the insulin solution or suspension in the vial and thereafter pulling the piston rod to move the piston in the tube to establish a subatmospheric pressure beneath that piston.

The injection needle may be of the G 30 type, but nothing guarantees that the content in the vial may be sucked through such a needle without any sieving effect occurs. Or in other words, it is not ensured that the crystals of a suspension in the vial are small enough to pass a G 30 needle without difficulties.

FIG. 2 shows an injection system comprising a pen shaped syringe comprising a housing 10 containing a dosing mechanism which enables the user to set a dose which is by a piston rod 11 and a piston 12 pressed from a cartridge 13 integrated in the pen out through an injection needle 15 which is carried in a needle hub 14 screwed onto the distal end of the integrated cartridge so that a proximal end of the needle pierces a rubber membrane closing the distal end of the cartridge. The pen may be used for injection of several doses. When not in use, the needle is protected by a cap 16 which further has a clip 17 making the pen storable in a pocket like a pencil. When the cartridge is empty, that is when the piston has been pressed all the way to the distal end of the cartridge, the whole unit with dosing mechanism and cartridge may be disposed of.

In this injection system it is ensured that the needle is only used with the integrated cartridge on which distal end it may be screwed, i.e. by falling the cartridge with an insulin type which has small crystals having an maximal size of 15 μm, this system ensures that G30 needle may be used without any risk of sieving effect on the insulin suspension when it is injected through such a needle.

In the system shown in FIG. 3 the pen syringe is of a reusable type in which a cartridge 22 is changed when empty. The pen syringe comprises a dosing part by which a piston rod 20 may successively be advanced to press a piston 21 into the cartridge 22 to press out corresponding doses of insulin through a needle 23 mounted at the distal end of the cartridge 22. The cartridge 22 is mounted in a cartridge holder comprising a tubular part 24 having at its proximal and distal ends guides 25 and 26, respectively, keeping the cartridge in a centered position in the holder.

The guide 26 at the distal end of the holder is so designed that a plastic cap 27 mounted on the neck part of the cartridge may protrude from the distal end of the syringe. The cap 27 carries an outer thread onto which may be mounted a needle hub with a G30 needle. In this way it is ensured that a G30 needle may only be mounted on a cartridge carrying a cap adapted to such a needle. When such caps are only mounted on cartridges filled with an insulin suspension having a crystal size <15 μm, i.e. an insulin type which may freely flow through a G30 needle, a safe injection system is provided.

Alternatively, the distal end of the cartridge holder may have a stud with an outer thread onto which a needle hub may be screwed. The injection system may then be made safe by taking care that the syringe can only be loaded with cartridges containing insulin suspensions wherein the crystal size is <15 μm.

FIG. 4 shows a needle hub with an embedded needle 30. The hub comprises a bottom 31 carrying a sleeve 31 which surrounds the needle concentrically at some distance. The sleeve has an internal thread 32 by which it may be screwed onto a hub receiving part of a syringe. A central protrusion 33 on the bottom 31 needle extends longitudinally along part of the needle 30 and forms a part of the embedment to let the needle be free only along the part of it which has to be inserted into the user during injection. In this way the risk of bending for breaking the needle is minimized.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US5300084 *Nov 23, 1992Apr 5, 1994United States Surgical CorporationPneumoperitoneum needle
US5360416 *Sep 30, 1993Nov 1, 1994Sherwood Medical CompanyThin-walled anesthesia needles
US5364374 *Sep 24, 1993Nov 15, 1994State Of OregonMicroneedle for injection of ocular blood vessels
US5462535 *Oct 14, 1994Oct 31, 1995Novo Nordisk A/SSyringe system
Non-Patent Citations
Reference
1"A Single-Blind, Randomized Study On The Degree Of Pain And Bleedings Using 27, 28, and 30 Gauge Needles", S.o slashed.rensen et al. 9th Workshop of the AIDSPIT Study Group, Jan. 28-30, 1990.
2"How to Avoid Clogging of Insulin Syringes", Diabetes Forecast 1976.
3"Hypodermic, Disposable Needles: Mechanical Properties and Pain Perception as a Function of Needle Diameter", by Lene Lytzen, Jun. 1991.
4 *A Single Blind, Randomized Study On The Degree Of Pain And Bleedings Using 27, 28, and 30 Gauge Needles , S rensen et al. 9th Workshop of the AIDSPIT Study Group, Jan. 28 30, 1990.
5 *How to Avoid Clogging of Insulin Syringes , Diabetes Forecast 1976 .
6 *Hypodermic, Disposable Needles: Mechanical Properties and Pain Perception as a Function of Needle Diameter , by Lene Lytzen, Jun. 1991.
7Poster entitled, "Determination of Pain on Needle Penetration Using 27, 28 and 30 Gauge Insuject Needles", S.o slashed.rensen et al. 9th Workshop of the AIDSPIT Study Group, Jan. 1990 p. 11, MedView 1987, vol. 1, No. 5.
8 *Poster entitled, Determination of Pain on Needle Penetration Using 27, 28 and 30 Gauge Insuject Needles , S rensen et al. 9th Workshop of the AIDSPIT Study Group, Jan. 1990 p. 11, MedView 1987, vol. 1, No. 5.
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6074371 *Sep 10, 1998Jun 13, 2000Magnolia Medical, LlcBlunt injection needle for a pen-type injector
US6146361 *Sep 26, 1996Nov 14, 2000Becton Dickinson And CompanyMedication delivery pen having a 31 gauge needle
US6200296Jun 5, 1997Mar 13, 2001Becton Dickinson And Company5mm injection needle
US6248093Oct 28, 1999Jun 19, 2001Minimed Inc.Compact pump drive system
US6277097 *Mar 20, 1998Aug 21, 2001Novo Nordisk A/SInjection system
US6362591Oct 28, 1999Mar 26, 2002Minimed Inc.Method and apparatus for detection of occlusions
US6555986Dec 13, 2001Apr 29, 2003Minimed Inc.Method and apparatus for detection of occlusions
US6585695Oct 28, 1999Jul 1, 2003Minimed Inc.Reservoir connector
US6595960Apr 12, 2001Jul 22, 2003Becton, Dickinson And CompanyFlexible needle assembly
US6613023Jul 11, 2001Sep 2, 2003Disetronic Licensing AgDevice for administering an injectable product in doses
US6699224Jul 11, 2001Mar 2, 2004Disetronic Licensing AgDevice for administering an injectable product
US6887253Nov 27, 2001May 3, 2005Steve SchragaLancet depth adjustment assembly
US6918918Apr 29, 2002Jul 19, 2005Steven SchragaSingle use lancet assembly
US6949111Feb 20, 2001Sep 27, 2005Steven SchragaLancet device
US6958072Jun 13, 2002Oct 25, 2005Steven SchragaSingle use lancet device
US7063684Feb 19, 2003Jun 20, 2006Medtronic Minimed, Inc.Drive system seal
US7193521Oct 22, 2003Mar 20, 2007Medtronic Minimed, Inc.Method and apparatus for detecting errors, fluid pressure, and occlusions in an ambulatory infusion pump
US7597682Oct 31, 2003Oct 6, 2009Medtronic Minimed, Inc.External infusion device with a vented housing
US7628772Dec 8, 2009Medtronic Minimed, Inc.Reservoir connector
US7628782Aug 20, 2004Dec 8, 2009Medtronic Minimed, Inc.Reservoir connector
US7658734Dec 23, 2002Feb 9, 2010Medtronic Minimed, Inc.Reservoir connector
US7678126May 3, 2005Mar 16, 2010Steven SchragaLancet depth adjustment assembly
US7892206Feb 22, 2011Medtronic Minimed, Inc.Method and apparatus for detecting errors, fluid pressure, and occlusions in an ambulatory infusion pump
US7988683Jan 25, 2010Aug 2, 2011Medtronic Minimed, Inc.Reservoir connector
US7998131Aug 16, 2011Medtronic Minimed, Inc.Reservoir connector
US8034069May 24, 2010Oct 11, 2011Steven SchragaSingle use lancet assembly
US8048097Jul 15, 2005Nov 1, 2011Steven SchragaSingle use lancet assembly
US8118825Nov 18, 2003Feb 21, 2012Steven SchragaLancet device
US8137325Apr 29, 2010Mar 20, 2012Novo Nordisk A/SNeedle mounting system and a method for mounting a needle assembly
US8257345Dec 4, 2009Sep 4, 2012Medtronic Minimed, Inc.Reservoir connector
US8273061Sep 25, 2012Medtronic Minimed, Inc.Reservoir connector
US8303572Nov 6, 2012Medtronic Minimed, Inc.Medication reservoir
US8318154Nov 27, 2012Halozyme, Inc.Super fast-acting insulin compositions
US8353924Oct 11, 2011Jan 15, 2013Stat Medical Devices, Inc.Single use lancet assembly
US8500716Sep 18, 2012Aug 6, 2013Medtronic Minimed, Inc.Medication reservoir
US8568713May 18, 2012Oct 29, 2013Halozyme, Inc.Super fast-acting insulin compositions
US8579869Feb 10, 2012Nov 12, 2013Novo Nordisk A/SNeedle mounting system and a method for mounting a needle assembly
US8715237Jan 27, 2011May 6, 2014Medtronic Minimed, Inc.Method and apparatus for detecting errors, fluid pressure, and occlusions in an ambulatory infusion pump
US8715309Feb 21, 2012May 6, 2014Steven SchragaLancet device
US8814896Jan 15, 2013Aug 26, 2014Stat Medical Devices, Inc.Single use lancet assembly
US8900186Feb 12, 2009Dec 2, 2014Becton, Dickinson And CompanyMicroneedle-based pen device for drug delivery and method for using same
US9034323Sep 24, 2013May 19, 2015Halozyme, Inc.Method for control of post-prandial glucose
US20030050656 *Jun 13, 2002Mar 13, 2003Steven SchragaSingle use lancet device
US20030125672 *Dec 23, 2002Jul 3, 2003Adair Randy W.Reservoir connector
US20030167039 *Feb 19, 2003Sep 4, 2003Medtronic Minimed, Inc.Drive system seal
US20040003493 *Jun 26, 2003Jan 8, 2004Minimed Inc.Reservoir connector
US20040034353 *Aug 11, 2003Feb 19, 2004Michelson Gary KarlinApparatus and method for anterior spinal stabilization
US20040039407 *Apr 29, 2002Feb 26, 2004Steven SchragaLancet device
US20040085215 *Oct 22, 2003May 6, 2004Medtronic Minimed, Inc.Method and apparatus for detecting errors, fluid pressure, and occlusions in an ambulatory infusion pump
US20040092873 *Oct 31, 2003May 13, 2004Medtronic Minimed Inc.External infusion device with a vented housing
US20050021000 *Aug 20, 2004Jan 27, 2005Minimed Inc.Reservoir connector
US20050046749 *Aug 23, 2004Mar 3, 2005Alps Electric Co., Ltd.Television tuner for both analog and digital signal
US20050070945 *Jul 20, 2004Mar 31, 2005Steven SchragaSingle use lancet assembly
US20060079920 *Jul 15, 2005Apr 13, 2006Steven SchragaSingle use lancet assembly
US20060178686 *Feb 7, 2005Aug 10, 2006Steven SchragaSingle use lancet device
US20070149926 *Feb 14, 2007Jun 28, 2007Medtronic Minimed, Inc.Method and Apparatus for Detecting Errors, Fluid Pressure, and Occlusions in an Ambulatory Infusion Pump
US20090157041 *Feb 12, 2009Jun 18, 2009Pettis Ronald JMicroneedel-based pen device for drug delivery and method for using same
US20100049135 *Nov 6, 2009Feb 25, 2010Medtronic Minimed, Inc.Reservoir connector
US20100049144 *Feb 25, 2010Medtronic Minimed, Inc.Reservoir connector
US20100082010 *Apr 1, 2010Medtronic Minimed, Inc.Reservoir connector
US20100125247 *Jan 25, 2010May 20, 2010Medtronic Minimed, Inc.Reservoir connector
US20100198243 *Aug 5, 2010Steven SchragaLancet depth adjustment assembly
US20100211014 *Apr 29, 2010Aug 19, 2010Novo Nordisk A/SNeedle Mounting System And A Method For Mounting A Needle Assembly
US20110119033 *May 19, 2011Medtronic Minimed, Inc.Method and Apparatus for Detecting Errors, Fluid Pressure, and Occlusions in an Ambulatory Infusion Pump
US20110238031 *Sep 29, 2011Medtronic Minimed, Inc.Medication reservoir
USD675316 *Jan 29, 2013Novo Nordisk A/SNeedle hub
EP1432466A2 *Sep 11, 2002Jun 30, 2004Becton, Dickinson and CompanyMicroneedle-based pen device for drug delivery and method for using same
EP2705850A2Apr 28, 2009Mar 12, 2014Halozyme, Inc.Super fast-acting insulin compositions
WO2011031458A1Aug 24, 2010Mar 17, 2011Medtronic Minimed, Inc.Reservoir barrier layer systems and methods
Classifications
U.S. Classification604/272, 604/232, 604/239
International ClassificationA61M5/24, A61M5/32, A61K38/28, A61M5/46
Cooperative ClassificationA61M5/32, A61M5/46, A61K38/28
European ClassificationA61K38/28, A61M5/32
Legal Events
DateCodeEventDescription
Aug 2, 2000FPAYFee payment
Year of fee payment: 4
Aug 25, 2004REMIMaintenance fee reminder mailed
Feb 4, 2005LAPSLapse for failure to pay maintenance fees
Apr 5, 2005FPExpired due to failure to pay maintenance fee
Effective date: 20050204